In utero and neonate exposure to nonylphenol develops hyperadrenalism and metabolic syndrome later in life. I. First generation rats (F 1)

Toxicology

Volumn 301, Issue 1-3, 2012, Pages 40-49

  Chang, Ling Ling ^a   Wun, Wan Song A ^b   Wang, Paulus S ^c,d,e  

^a CHINESE CULTURE UNIVERSITY   (Taiwan)

^b Obstetrical and Gynecological Associates   (United States)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

^d CHINA MEDICAL UNIVERSITY   (Taiwan)

^e TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

11 HSD1; Body weight; Developmental exposure; Hyperadrenalism; Metabolic syndrome; NP

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE 1; ALDOSTERONE; ALDOSTERONE SYNTHASE; BETA ACTIN; CORTICOSTERONE; CORTICOTROPIN; NONYLPHENOL; STEROID 11BETA MONOOXYGENASE; STEROIDOGENIC ACUTE REGULATORY PROTEIN;

ADIPOSE TISSUE; ADRENAL FUNCTION; ALDOSTERONE BLOOD LEVEL; ANIMAL EXPERIMENT; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; CORTICOTROPIN BLOOD LEVEL; FEMALE; HYPERADRENOCORTICISM; LACTATION; MALE; METABOLIC SYNDROME X; NEWBORN; NONHUMAN; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TISSUE LEVEL; ZONA GLOMERULOSA;

ADIPOSE TISSUE; ADRENOCORTICAL HYPERFUNCTION; ADRENOCORTICOTROPIC HORMONE; ALDOSTERONE; ANIMALS; BODY WEIGHT; CORTICOSTERONE; ENDOCRINE DISRUPTORS; FEMALE; LIVER; MALE; METABOLIC SYNDROME X; PHENOLS; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RATS; RATS, SPRAGUE-DAWLEY;

RATTUS;

EID: 84864801555     PISSN: 0300483X     EISSN: 18793185     Source Type: Journal    
DOI: 10.1016/j.tox.2012.06.017     Document Type: Article

References (70)

1. Ademollo N., Ferrara F., Delise M., Fabietti F., Funari E. Nonylphenol and octylphenol in human breast milk. Environ. Int. 2008, 34:984-987.
2. Atkinson H.C., Waddell B.J. Circadian variation in basal plasma corticosterone and adrenocorticotropin in the rat: sexual dimorphism and changes across the estrous cycle. Endocrinology 1997, 138:3842-3848.
3. Baillie-Hamilton P.F. Chemical toxins: a hypothesis to explain the global obesity epidemic. J. Altern. Complement. Med. 2002, 8:185-192.
4. Baquedano E., Garcia-Caceres C., Diz-Chaves Y., Lagunas N., Calmarza-Font I., Azcoitia J., Garcia-Segura L.M., Argente J., Chowen J.A., Frago L.M. Prenatal stress induces long-term effects in cell turnover in the hippocampus-hypothalamus-pituitary axis in adult male rats. PLoS One 2011, 6:e227549.
5. Barker D.J. The origins of developmental origins theory. J. Intern. Med. 2007, 261:412-417.
6. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72:248-254.
7. Brown A.P., Dinger N., Levine B.S. Stress produced by gavage administration in the rat. Contemp. Top. Lab. Anim. Sci. 2000, 39:17-21.
8. Calafat A.M., Kuklenyik Z., Reidy J.A., Caudill S.P., Ekong J., Needham L.L. Urinary concentrations of bisphenol A and 4-nonylphenol in a human reference population. Environ. Health Perspect. 2005, 113:391-395.
9. Campbell J.E., Peckett A.J., D'souza A.M., Hawke T.J., Riddell M.C. Adipogenic and lipolytic effect of chronic glucocorticoid exposure. Am. J. Physiol. Cell. Physiol. 2011, 300:C198-C209.
10. Carson R. Silent Spring 1962, Houghton Mifflin, Boston.
11. Chang L.L., Tseng Y.C., Lin Y.L., Wun W.S.A., Wang P.S. Effects of S-petasin on corticosterone release in rats. Chin. J. Physiol. 2002, 45:137-142.
12. Chang L.L., Wun Alfred W.S., Wang P.S. Effects and mechanisms of nonylphenol on corticosterone release in rat zona fasciculata-reticularis cells. Toxicol. Sci. 2010, 118:411-419.
13. Chang L.L., Wun Alfred W.S., Wang P.S. Effects and of nonylphenol on aldosterone release from rat zona glomerulosa cells. Chem. Biol. Interact. 2012, 195:11-17.
14. Chang Y.-J., Huang W-J., Lin H.-W., Chang L.-L., Chang F.-Y., Wang P.S. A radioimmunoassay for rat ghrelin: evaluation of method and effects of nonylphenol on ghrelin secretion in force-fed young rats. Chin. J. Physiol. 2011, 54:324-331.
15. Chapin R.E., Delaney J., Wang Y., Lanning L., Davis B., Collins B., Mintz N., Wolfe G. The effects of 4-nonylphenol in rats: a multigeneration reproduction study. Toxicol. Sci. 1999, 52:80-91.
16. Chen G.W., Ding W.H., Ku H.Y., Chao H.R., Chen H.Y., Huang M.C., Wang S.L. Alkylphenols in human milk and their relations to dietary habits in central Taiwan. Food Chem. Toxicol. 2010, 48:1939-1944.
17. Chen M.-L., Chang C.-C., Shen Y.-J., Hung J.-H., Guo B.-R., Chuang H.-Y., Mao I.-F. Quantification of prenatal exposure and maternal fetal transfer of nonylphenol. Chemosphere 2008, 73:S239-S245.
18. Colborn T., Dumanoski D., Meyers J.P. Our Stolen Future: Are We Threatening Our Fertility, Intelligence, and Survival? - A Scientific Detective Story 1996, Penguin Group, New York.
19. Cooper M.S., Stewart P.M. 11β-Hydroxysteroid dehydrogenase type 1 and its role in the hypothalamus-pituitary adrenal axis, metabolic syndrome, and inflammation. J. Clin. Endocrinol. Metab. 2009, 94:4645-4654.
20. Crofton J.T., Ratiff D.L., Brooks D.P., Share L. The metabolic clearance rate of and pressor responses to vasopressin in male and female rats. Endocrinology 1986, 118:1777-1781.
21. Cunny H.C., Mayes B.A., Rosica K.A., Trutter J.A., Van Miller J.P. Subchronic toxicity (90-day) study with para-nonylphenol in rats. Regul. Toxicol. Pharmacol. 1997, 26:172-178.
22. D'Eon T.M., Souza S.C., Aronovitz M., Obin M.S., Fried S.K., Greenberg A.S. Estrogen regulation of adiposity and fuel partitioning-evidence of genomic and non-genomic regulation of lipogenic and oxidative pathways. J. Biol. Chem. 2005, 280:35983-35991.
23. Dicker A., Ryden M., Naslund E., Muehlen I.E., Wiren M., Lafontan M., Arner P. Effect of testosterone on lipolysis in human pre-adipocytes from different fat depots. Diabetologia 2004, 47:420-428.
24. Edwards T.M., Myers J.P. Environmental exposure and gene regulation in disease etiology. Environ. Health Perspect. 2007, 115:1264-1270.
25. Eijken M., Hewison M., Cooper M.S., de Jong F.H., Chiba H., Stewart P.M., Uitterlinden A.G., Pols H.A., van Leeuwen J.P. 11beta-Hydroxysteroid dehydrogenase expression and glucocorticoid synthesis are directed by a molecular switch during osteoblast differentiation. Mol. Endocrinol. 2005, 19:621-631.
26. Feng Y., Huang S.L., Dou W., Zhang S., Chen J.H., Shen Y., Shen J.H., Leng Y. Emodin, a natural product, selectively inhibits 11beta-hydroxysteroid dehydrogenase type 1 and ameliorates metabolic disorder in diet-induced obese mice. Br. J. Pharmacol. 2010, 161:113-126.
27. Ferguson S.A., Scallet A.C., Flynn K.M., Meredith J.M., Schwetz B.A. Developmental neurotoxicity of endocrine disrupters: focus on estrogens. Neurotoxicology 2000, 21:947-956.
28. Ferguson S.A., Delclos K.B., Newbold R.R., Flynn K.M. Few effects of multi-generational dietary exposure to genistein or nonylyphenol on sodium solution intake in male and female Sprague-Dawley rats. Neurotoxicol. Teratol. 2009, 31:143-148.
29. Ferrara F., Ademollo N., Orru M.A., Silvestroni L., Funari E. Alkylphenols in adipose tissues of Italian populaton. Chemosphere 2011, 82:1044-1049.
30. Garcia-Caceres C., Lagunas N., Calmarza-Font I., Azcoitia I., Diz-Chaves Y., Garcia-Sequra L.M., Baquedano E., Frago L.M., Argente J., Chowen J.A. Gender differences in the long-term effect of chronic prenatal stress on the HPA axis and hypothalamic structure in rats. Psychoneuroendocrinology 2010, 35:1525-1535.
31. Gathercole L.L., Morgan S.A., Bujalska I.J., Hauton D., Stewart P.M., Tomlinson J.W. Regulation of lipogenesis by glucocorticoids and insulin in human adipose tissue. PLoS One 2011, 6:e26223.
32. Geerling J.C., Loewy A.D. Central regulation of sodium appetite. Exp. Physiol. 2008, 93:177-209.
33. 125I-labelled human growth hormone of high specific activity. Biochem. J. 1963, 89:114-123.
34. Grun F., Blumbeg B. Environmental obesogens: organotins and endocrine disruption via nuclear receptor signaling. Endocrinology 2006, 147(Suppl. 6):S50-S55.
35. Hatch E.E., Palmer J.R., Titus-Ernstoff L., Noller K.L., Kaufman R.H., Mittendorf R., Robboy S.J., Hyer M., Cowan C.M., Adam E., Colton T., Hartge P., Hoover R.N. Cancer risk in women exposed to diethylstilbestrol in utero. JAMA 1998, 280:630-634.
36. Herbst A.L., Ulfelder H., Poskanzer D.C. Adenocarcinoma of the vagina: association of maternal stilbestrol therapy with tumor appearance in young women. N. Engl. J. Med. 1971, 284:878-881.
37. Holtcamp W. Obesogens an environmental link to obesity. Environ. Health Perspect. 2012, 120:A62-A68.
38. Hossaini A., Dalgaard M., Vinggaard A.M., Frandsen H., Larsen J.-J. In utero reproductive study in rats exposed to nonylphenol. Reprod. Toxicol. 2001, 15:537-543.
39. 1 male rats. Birth Defects Res. B: Dev. Reprod. Toxicol. 2010, 89:418-428.
40. Jing X., Bing S., Xiaoyan W., Xiaojie S., Yongning W. A study on bisphenol A, nonylphenol, and octylphenol in human urine samples detected by SPE-UPLC-MS. Biomed. Environ. Sci. 2011, 24:40-46.
41. Kau M.M., Chen J.J., Wang S.W., Cho W.L., Wang P.S. Age-related impairment of aldosterone secretion in zona glomerulosa cells of ovariectomized rats. J. Invest. Med. 1999, 47:425-432.
42. Kearney P.M., Whelton M., Reynolds K., Muntner P., Whelton J.K., He J. Global burden of hypertension: analysis of worldwide data. Lancet 2005, 365:217-223.
43. Laws S.C., Carey S.A., Ferrell J.M., Bodman G.J., Cooper R.L. Estrogenic activity of octylphenol, nonylphenol, bispenol A and methoxychlor in rats. Toxicol. Sci. 2000, 54:154-167.
44. Lo M.J., Kau M.M., Chen Y.H., Tsai S.C., Chiao Y.C., Chen J.J., Liaw C., Lu C.C., Lee B.P., Chen S.C., et al. Acute effects of thyroid hormones on the production of adrenal cAMP and corticosterone in male rats. Am. J. Physiol. 1998, 274:E238-E245.
45. Lo M.J., Chang L.L., Wang P.S. Effect of estradiol on corticosterone secretion in ovariectomized rats. J. Cell. Biochem. 2000, 77:560-568.
46. Lopez-Espinosa M.J., Freire C., Arrebola J.P., Navea N., Taoufiki J., Fernandez M.F., Ballesteros O., Prada R., Olea N. Nonylphenol and octylphenol in adipose tissue of women in southern Spain. Chemosphere 2009, 76:847-852.
47. Mariniello B., Ronconi V., Rilli S., Bernante P., Boscaro M., Mantero F., Giacchetti G. Adipose tissue 11β-hydroxysteroid dehydrogenase type 1 expression in obesity and Cushing's syndrome. Eur. J. Endocrinol. 2006, 155:435-441.
48. McCormick K.L., Wang X., Mick G.J. Evidence that the 11 beta-hydroxysteroid dehydrogenase (11 beta-HSD1) is regulated by pentose pathway flux. Studies in rat adipocytes and microsomes. J. Biol. Chem. 2006, 281:341-347.
49. 10T1/2 cells into osteoblast and adipocyte lineages. Toxicol. Sci. 2008, 102:82-88.
50. Nagao T., Wada K., Marumo H., Yoshimura S., Ono H. Reproductive effects of nonylphenol in rats after gavage administration: a two generation study. Reprod. Toxicol. 2001, 15:293-315.
51. Newbold R.R., Padilla-Banks E., Snyder R.J., Phillips T.M., Jefferson W.N. Developmental exposure to endocrine disruptors and obesity epidemic. Reprod. Toxicol. 2007, 23:290-296.
52. Oki K., Gomez-Sanchez E.P., Gomez-Sanchez C.E. Role of mineralcorticoid action in the brain in salt-sensitive hypertension. Clin. Exp. Pharmacol. Physiol. 2012, 39:90-95.
53. Padwal R.S., Sharma A.M. Prevention of cardiovascular disease: obesity, diabetes, and the metabolic syndrome. Can. J. Cardiol. 2010, 26(Suppl. C):18C-20C.
54. Palin S.L., McTernan P.G., Anderson L.A., Sturdee D.W., Barnett A.H., Kumar S. 17 beta-Estradiol and anti-estrogen ICI: compound 182,780 regulate expression of lipoprotein and hormone-sensitive lipase in isolated subcutaneous abdominal adipocytes. Metabolism 2003, 52:383-388.
55. Pereira C.D., Azevedo I., Monteiro R., Martins M.J. 11β-Hydroxysteroid dehydrogenase type 1: relevance of its modulation in pathophysiology of obesity, the metabolic syndrome and type two diabetes mellitus. Diabetes Obes. Metab. 2012, 10.1111/j.1463-1326.2012.01582.x.
56. Seckl J.R. Prenatal glucocorticoids and long-term programming. Eur. J. Endocrinol. 2004, 151:U49-U62.
57. Seki Y., Williams L., Vuguin P.M., Charron M.J. Minireview: epigenetic programming of diabetes and obesity: animal models. Endocrinology 2012, 153:1031-1038.
58. Shankar A., Teppala S. Urinary bisphenol A and hypertension in a multiethnic sample of US adults. J. Environ. Public Health 2012, 2012:481641.
59. Shukla V.H., Dave K.R., Katyare S.S. Effect of catecholamine depletion on oxidative energy metabolism in rat liver, brain and heart mitochondria; use of reserpine. Comp. Biochem. Physiol. C: Toxicol. Pharmacol. 2000, 127:79-90.
60. Steel R.G.D., Torrie J.H. Principles and Procedures of Statistics 1960, McGraw-Hill, New York.
61. Stimson R.H., Walker B.R. Glucocorticoids and 11 beta-hydroxysteroid dehydrogenase type 1 in obesity and the metabolic syndrome. Minerva Endocrinol. 2007, 32:141-159.
62. Swegert C.V., Dave K.R., Katyare S.S. Effects of aluminum-induced Alzheimer like condition on oxidative energy metabolism in rat liver, brain and heart mitochondria. Mech. Ageing Dev. 1999, 112:27-42.
63. Torres-Farfan C., Mendez N., Abarzua-Catalan L., Vilches N., Valenzuela G.J., Seron-Ferre M. A circadian clock entrained by melatonin is ticking in the rat fetal adrenal. Endocrinology 2011, 152:1891-1900.
64. Wada K., Sakamoto H., Nishikawa K., Sakuma S., Nakajima A., Fujimoto Y., Kamisaki Y. Life style-related diseases of the digestive system: endocrine disruptors stimulate lipid accumulation in target cells related to metabolic syndrome. J. Pharmocol. Sci. 2007, 105:133-137.
65. Wan Z.K., Chenail E., Li H.Q., Kendall C., Wang Y., Gingras S., Xiang J., Massefski W.W., Mansour T.S., Saiah E. Synthesis of potent and orally efficacious 11β-hydroxysteroid dehydrogenase type 1 inhibitor HSD-016. J. Org. Chem. 2011, 76:7048-7055.
66. Wang P.S., Yu W.H., Chen Y.Y. Radioimmunoassay for gonadotropin-releasing hormone: evaluation of method and applications. Chin. J. Physiol. 1983, 26:93-106.
67. Waterland R.A., Michelis K.B. Epigenetic epidemiology of the developmental origins hypothesis. Annu. Rev. Nutr. 2007, 27:363-388.
68. Weitzman E.D., Fukushima D., Nogeire C., Roffwarg H., Gallagher T.F., Hellman L. Twenty-four hour pattern of the episodic secretion of cortisol in normal subjects. J. Clin. Endocrinol. Metab. 1971, 33:14-22.
69. Wilson V.S., Bobseine K., Gray L.E. Development and characterization of a cell line that stably expresses an estrogen-responsive luciferase reporter for the detection of estrogen receptor agonist and antagonist. Toxicol. Sci. 2004, 81:69-77.
70. Xu X., De Pergola G., Bjorntorp P. The effect of androgens on the regulation of lipolysis in adipose precursor cells. Endocrinology 1990, 126:1229-1234.